The FDA is seeking changes to some topical antiseptics' packaging and labels to lower infection risks. Contamination can take place during production because the sterility of topical antiseptics is not a requirement in the process. Manufacturers are urged by the agency to voluntarily change labels to point out whether a drug is produced as sterile or nonsterile. Also, the FDA is urging that topical antiseptics be manufactured in single-use sizes to avoid contamination by the user.

Related Summaries